OPRX - OptimizeRx Non-GAAP EPS of $0.22 beats by $0.18 revenue of $20.3M beats by $5.5M February, 24 2022 04:49 PM OptimizeRx Corporation OptimizeRx press release (NASDAQ:OPRX): Q4 Non-GAAP EPS of $0.22 beats by $0.18. Revenue of $20.3M (+23.6% Y/Y) beats by $5.5M. For further details see: OptimizeRx Non-GAAP EPS of $0.22 beats by $0.18, revenue of $20.3M beats by $5.5M